Similar articles for PMID: 31892585

Year	Number of Results
1997	1
1998	2
2000	1
2001	1
2002	2
2005	1
2006	3
2007	1
2008	2
2009	2
2010	1
2011	2
2012	2
2013	3
2014	1
2015	11
2016	15
2017	11
2018	10
2019	4
2020	3
2024	0

1

Role of COX2 as a Biomarker for Estimating Survival of Patients With Clinical Stage I Gastric Cancer.

Yoo HJ, Kim TJ, Kim DJ, Kim W. Yoo HJ, et al. Anticancer Res. 2020 Jan;40(1):341-347. doi: 10.21873/anticanres.13958. Anticancer Res. 2020. PMID: 31892585

2

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. Mrena J, et al. J Clin Pathol. 2006 Jun;59(6):618-23. doi: 10.1136/jcp.2005.033761. J Clin Pathol. 2006. PMID: 16731602 Free PMC article.

3

Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.

Sano Y, Kogashiwa Y, Araki R, Enoki Y, Ikeda T, Yoda T, Nakahira M, Sugasawa M. Sano Y, et al. Otolaryngol Head Neck Surg. 2018 Apr;158(4):667-676. doi: 10.1177/0194599817745284. Epub 2018 Jan 23. Otolaryngol Head Neck Surg. 2018. PMID: 29359615

4

Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.

Ma WJ, Wang X, Yan WT, Zhou ZG, Pan ZZ, Chen G, Zhang RX. Ma WJ, et al. World J Gastroenterol. 2018 May 28;24(20):2181-2190. doi: 10.3748/wjg.v24.i20.2181. World J Gastroenterol. 2018. PMID: 29853736 Free PMC article.

5

Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation.

Pérez-Ruiz E, Cazorla O, Redondo M, Pérez L, Álvarez M, Gallego E, Trigo JM, Medina JA, Matilla A, Rueda A. Pérez-Ruiz E, et al. Clin Transl Oncol. 2012 Sep;14(9):682-8. doi: 10.1007/s12094-012-0859-2. Epub 2012 Jul 24. Clin Transl Oncol. 2012. PMID: 22855152

6

Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.

Aggarwal A, Al-Rohil RN, Batra A, Feustel PJ, Jones DM, DiPersio CM. Aggarwal A, et al. BMC Cancer. 2014 Jun 20;14:459. doi: 10.1186/1471-2407-14-459. BMC Cancer. 2014. PMID: 24950714 Free PMC article.

7

[Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].

Zhang R, Song Y, Gao WJ, Zhang X, Zuo J, Lei CZ, Wang Y. Zhang R, et al. Zhonghua Yi Xue Za Zhi. 2009 Dec 22;89(47):3341-5. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20193563 Chinese.

8

COX2 overexpression is a prognostic marker for Stage III breast cancer.

Kim HS, Moon HG, Han W, Yom CK, Kim WH, Kim JH, Noh DY. Kim HS, et al. Breast Cancer Res Treat. 2012 Feb;132(1):51-9. doi: 10.1007/s10549-011-1521-3. Epub 2011 Apr 28. Breast Cancer Res Treat. 2012. PMID: 21533532

9

EpCAM and COX‑2 expression are positively correlated in human breast cancer.

Gao S, Sun Y, Liu X, Zhang D, Yang X. Gao S, et al. Mol Med Rep. 2017 Jun;15(6):3755-3760. doi: 10.3892/mmr.2017.6447. Epub 2017 Apr 7. Mol Med Rep. 2017. PMID: 28393249

10

Cyclooxygenase-2 (COX2) and p53 protein expression are interdependent in breast cancer but not associated with clinico-pathological surrogate subtypes, tumor aggressiveness and patient survival.

Serra KP, Peres RM, Sarian LO, Vassallo J, Pinto GA, Silva GR, Soares FA, da Cunha IW, Espinola J, Bento AM, Del Corso LM, Derchain S. Serra KP, et al. Acta Histochem. 2016 Mar;118(2):176-82. doi: 10.1016/j.acthis.2015.12.009. Epub 2016 Jan 11. Acta Histochem. 2016. PMID: 26791786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year